Heat Shock Protein 90 c-Terminal Inhibitors in Cancer Treatment
<p>Heat shock protein 90 (Hsp90) is 90 kDa highly conserved dimeric chaperone protein in prokaryotic and eukaryotic cells and it is localized in different parts of the cell. Hsp90AA1 (inducible) and Hsp90AB1 (constitutive) are available in the cytosol; Grp94 and TRAP1 exist in endoplasmic reti...
Saved in:
Main Author: | Yusuf Tutar (Author) |
---|---|
Format: | Book |
Published: |
International Journal of Pharmaceutical Sciences and Developmental Research - Peertechz Publications,
2015-05-16.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discovery and development of natural heat shock protein 90 inhibitors in cancer treatment
by: Yong Li, et al.
Published: (2012) -
Heat Shock Protein 90 (Hsp90) Expression and Breast Cancer
by: Christos A. Papadimitriou, et al.
Published: (2012) -
Heat Shock Protein 90 and Role of Its Chemical Inhibitors in Treatment of Hematologic Malignancies
by: Haojian Zhang, et al.
Published: (2012) -
Effects of Heat Shock Protein 90 Inhibition In the Lungs
by: Mohammad A. Uddin, et al.
Published: (2020) -
Therapeutic Potential of Heat Shock Protein 90 Inhibitors, Geldanamycin, and Analog Compounds in Precision Cancer Therapy
by: Atta Mohammed Alzebari, et al.
Published: (2023)